Biogen Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | $6.51B | $12.14B | $2.33B |
| FY2017 | $5.94B | $12.61B | $1.57B |
| FY2018 | $5.94B | $13.04B | $1.22B |
| FY2019 | $4.46B | $13.34B | $2.91B |
| FY2020 | $7.43B | $10.70B | $1.33B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | $6.51B | $12.14B | $2.33B |
| FY2017 | $5.94B | $12.61B | $1.57B |
| FY2018 | $5.94B | $13.04B | $1.22B |
| FY2019 | $4.46B | $13.34B | $2.91B |
| FY2020 | $7.43B | $10.70B | $1.33B |